Other Industries
What to look for when Progenics Pharma posts Q2 earnings
Progenics Pharmaceuticals (NASDAQ: PGNX) is set to release its earnings results for the second quarter of 2019 on Friday before…
Ionis Pharmaceuticals stock surges on Q2 earnings beat
Ionis Pharmaceuticals (NASDAQ: IONS) reported better-than-expected second quarter results pushing the stock above 3% in the pre-market trading hours. The…
Earnings: CVS Health Q2 results beat estimates; raises FY19 guidance
Revenues of healthcare company CVS Health (NYSE: CVS) rose sharply in the second quarter and exceeded the estimates. As a…
Wynn Resorts Q2 earnings in line with estimates
Wynn Resorts (NASDAQ: WYNN) stock surged above 4% after the bell after the casino operator reported better-than-expected second quarter results.…
New study shows cord-cutting in the US will continue to increase
A new report from eMarketer suggests that the trend of cord-cutting in the US will continue to increase at a…
Aurora Cannabis reiterates revenue outlook for Q4, FY19
Cannabis producer Aurora Cannabis (NYSE: ACB) reiterated its production and revenue guidance for the fourth quarter and fiscal 2019 after…
Alnylam Pharmaceuticals posts narrower-than-expected Q2 loss
Alnylam Pharmaceuticals (NASDAQ: ALNY) reported a wider loss in the second quarter of 2019 due to higher costs and expenses.…
Vericel reports Q2 earnings beat, raises outlook
Vericel Corporation (NASDAQ: VCEL) reported better-than-expected results in the second quarter aided by strong growth from both of its products.…
Allergan tops Q2 views; lifts 2019 revenue outlook
Allergan plc (NYSE: AGN) surpassed market's expecations for Q2. The company also lifted its revenue outlook for full-year 2019. Non-GAAP…
Regeneron Q2 earnings, revenue top expectations on strong product sales
Regeneron Pharmaceuticals (NASDAQ: REGN) reported an increase in earnings for the second quarter, when revenues grew by 20% helped by…
Marriott Q2 earnings in line with estimates, but revenue fails to impress
Marriott International (NASDAQ: MAR) stock slipped about 3% after the bell as the second quarter earnings came in line with…